© 2003 by European Society of Cardiology
Pacemaker prevention therapies for the control of drug-refractory paroxysmal atrial fibrillation
Regional Cardiac Centre, Wythenshawe Hospital Manchester, U.K.
AIMS: Atrial septal pacing has been shown to prevent paroxysmal atrial fibrillation (PAF) refractory to drugs in patients without inappropriate bradycardia. This study assesses the effects of atrial septal pacing using new pacing algorithms designed to prevent the initiation or maintenance of PAF.
METHODS AND RESULTS: Eleven Medtronic AT500 and 6 Guidant Pulsar Max pacemakers were implanted. The incremental benefit of prevention pacing therapies was compared with DDDR pacing by analysis of pacemaker-stored electrograms, ambulatory electrocardiography, symptoms and quality of life questionnaires.
RESULTS: Atrial septal pacing reduced AF burden by >50% in 13/17 patients (76·5%). Activation of a combined pacing algorithm (atrial pacing preference; atrial rate stabilization; and post mode-switch overdrive pacing) in patients with AT500 pacemakers produced a marginal reduction in AF burden (mean %AF 0·61 ON, 0·73 OFF, P=0·53 ns). Conversely in the Pulsar Max group when atrial pacing preference was activated, AF burden was slightly increased (mean %AF 5·84 ON, 3·73 OFF,P =0·13). Symptoms improved with atrial septal pacing but did not change when prevention algorithms were activated.
CONCLUSION: Atrial septal pacing resulted in a marked improvement in AF burden and symptoms. Activation of specific prevention pacing algorithms provided more continuous atrial pacing but had limited and heterogeneous effects on AF burden.
Key Words: Atrial septum, atrial fibrillation, preventive pacing for atrial fibrillation, atrial septal pacing
Correspondence: Dr M. Kale, Specialist Registrar Cardiology, Department of Cardiology, North Manchester General Hospital, Delaunays Road, Manchester, Delaunays Road, Crumpsall, Manchester, M8 5RB. Tel.: 0161 720 2579/2776; Fax: 0161 720 2741; E-mail: mkale{at}onetel.net.uk
[1] Allessie MA, Konigs K, Kirchhof CJ, Wijffels M. Electrophysiologic mechanisms in the perpetuation of atrial fibrillation. Am J Cardiol 1996; 77: 10–23.[CrossRef][Web of Science][Medline]
[2] Jalife J, Berenfeld O, Skanes A, Mandapati R. Mechanisms of atrial fibrillation: Mother's rotors or multiple daughter wavelets or both? J Cardiovasc Electrophysiol 1998; 9: S2–12.[Web of Science][Medline]
[3] Gillis AM. Pacing to prevent atrial fibrillation. Cardiol Clin 2000; 18: 25–36.[CrossRef][Medline]
[4] Tsuji H, Fujiki A, Tani M, Yoshida S, Sasayama S. Quantitative relationship between atrial refractoriness and the dispersion of refractoriness in atrial vulnerability. Pacing Clin Electrophysiol 1992; 15: 402–410.
[5] Disertori M, Padeletti L, Santini M, et al. Antitachycardia pacing to terminate atrial tachyarrhythmias: the AT500 Italian Registry. Eur Heart J 2001; Suppl 3:suppl P, 16–24.
[6] Lam CT, Lau CP, Leung SK, et al. Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation. Europace 2000; 2: 286–291.
[7] Bennett DH. Comparison of the acute effects of pacing the atrial septum, right atrial appendage, coronary sinus os, and the latter two sites simultaneously on the duration of atrial activation. Heart 2000; 84: 193–196.
[8] Padeletti L, Pieragnoli P, Ciapetti C, et al. Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J 2001; 142: 1047–1055.[CrossRef][Web of Science][Medline]
[9] Padeletti L, Porciani MC, Michelucci AV, et al. Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation. J Interv Card Electrophysiol 1999; 3: 35–43.[CrossRef][Web of Science][Medline]
[10] Boriani G, Biffi M, Padeletti L, et al. Effects of consistent atrial pacing and atrial rate stabilization — two pacing algorithms to suppress recurrent paroxysmal atrial fibrillation in brady-tachy syndrome. Eur Heart J Suppl 2001; 3:suppl P, 7–15.
[11] Spencer WH 3rd, Zhu DW, Markowitz T, Badruddin SM, Zoghbi WA. Atrial septal pacing: a method for pacing bothatria simultaneously. Pacing Clin Electrophysiol 1997; 20: 2739–2745.[CrossRef][Medline]
[12] Katsivas A, Manolis AG, Lazaris E, Vassilopoulos C, Louvros N. Atrial septal pacing to synchronize atrial depolarization in patients with delayed interatrial conduction. Pacing Clin Electrophysiol 1998; 21: 2220–2225.[CrossRef][Medline]
[13] Kale M and Bennett DH. Atrial septal pacing in the prevention of paroxysmal atrial fibrillation refractory to antiarrhythmic drugs. Int J Cardiol 2002; 82: 167–175.[CrossRef][Web of Science][Medline]
[14] Manolis AG, Katsivas AG, Vassilopoulos C, Koutsogeorgis D, Louvros NE. Prevention of atrial fibrillation by interatrial septum pacing guided by electrophysiological testing in patients with delayed interatrial conduction. Europace 2002; 4: 165–174.
[15] Pollak WM, Simmons JD, Interian A, et al. Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial fibrillation and flutter. Pacing Clin Electrophysiol 2001; 24: 424–429.[CrossRef][Medline]
[16] Savelieva I and Camm AJ. Silent atrial fibrillation — Another Pandora's box. Pacing Clin Electrophysiol 2000; 23: 145–148.[CrossRef][Medline]
[17] Dorian P, Jung W, Newman D, et al. The impairment of health-related quality of life patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 2000; 36: 1303–1309.
[18] Jenkins LS and Bubien RS. Quality of life in patients with atrial fibrillation. Cardiol Clin 1996; 14: 597–606.[Medline]
[19] Bubien RS, Kay GN, Jenkins LS. Test specifications for symptom checklist: Frequency and severity 1993; Milwaukee University of Wisconsin, Milwaukee.
[20] Ware JE and Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). I.Conceptual framework and item selection. Med Care 1992; 30: 473–478.[Web of Science][Medline]
[21] Israel CW, Hugl B, Unterberg C, et al. The AT500 Verification Study Investigators Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001; 12: 1121–1128.[CrossRef][Web of Science][Medline]
[22] Daubert JC and Mabo P. Atrial pacing for the prevention of postoperative atrial fibrillation: how and where to pace? J Am Coll Cardiol 2000; 35: 1423–1427.
[23] Vardas PE. Nonpharmacological treatment of atrial fibrillation. Pacing Clin Electrophysiol 2000; 23: 395–401.[Medline]
[24] Prakash A. Pacing for the prevention of atrial fibrillation. Curr Opin Cardiol 2002; 17: 73–81.[Medline]
[25] Bailin SJ, Adler S, Giudici M. Prevention of chronic atrial fibrillation by pacing in the region of Bachmann's bundle: results of a multicenter randomized trial. J Cardiovasc Electrophysiol 2001; 12: 912–917.[CrossRef][Web of Science][Medline]
[26] Yu WC, Tsai CF, Hsieh MH, et al. Prevention of the initiation of atrial fibrillation: mechanism and efficacy of different atrial pacing modes. Pacing Clin Electrophysiol 2000; 23: 373–379.[CrossRef][Medline]
[27] Niwano S, Yamaura M, Washizuka T, et al. Comparison of arrhythmogenicity of atrial pacing at several right atrial pacing sites: evaluation of canine atrial electrograms during atrial pacing and arrhythmogenicity for atrial fibrillation. Pacing Clin Electrophysiol 1998; 21: 1918–1926.[CrossRef][Medline]
[28] Padeletti I, Pieragnoli P, Ciapetti C, et al. Prevention of paroxysmal atrial fibrillation by permanent septal atrial pacing: long-term follow up. Eur Heart J Suppl 2001; 3:Suppl P, 2–6.
[29] de Cock CC, Meyer A, Kamp O, Visser CA. Hemodynamic benefits of right ventricular outflow tract pacing: comparison with right ventricular apex pacing. Pacing Clin Electrophysiol 1998; 21: 536–541.[CrossRef][Medline]
[30] Kolettis TM, Kyriakides ZS, Tsiapras D, Popov T, Paraskevaides IA, Kremastinos DT. Improved left ventricular relaxation during short-term right ventricular outflow tract compared to apical pacing. Chest 2000; 117: 60–64.
[31] Plummer CJ, Henderson S, Gardener L, McComb JM. The use of permanent pacemakers in the detection of cardiac arrhythmias. Europace 2001; 3: 229–232.
[32] Carlson M. M St Jude Medical ADOPT-A trial result report. 22nd Scientific Sessions NASPE 5 May 2001, Boston, MA, USA. Available from URL: http://www.crsolutions.com.au/CRS.News.St.Jude.html.
[33] Saksena S, Prakash A, Ziegler P, et al. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 2002; 40: 1140–1150.
[34] Camm J. AFtherapy Study: Preventing Pacing for Paroxsymal Atrial Fibrillation. Abstract (publishing ID:125) presented at 23rd Scientific Sessions NASPE May 8–11 2002, San Diego, CA, USA.
[35] Padeletti L, Purerfellner H, Adler S, et al. Atrial Septal Lead Placement and Atrial Pacing Algorithms for Prevention of Paroxysmal Atrial Fibrillation: ASPECT Study Results. Abstract (publishing ID:659) presented at 23rd Scientific Sessions NASPE May 8–11 2002, SanDiego, CA, USA.
[36] Lee MA, Weachter R, Pollak S, et al. Can Preventive and Antitachycardia Pacing Reduce the Frequency and Burden of Atrial Tachyarrhythmias? The ATTEST Study Results. Abstract (publishing ID:74) presented at 23rd Scientific Sessions NASPE May 8–11 2002, San Diego, CA, USA.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. K. Kantharia, R. A. Freedman, D. Hoekenga, G. Tomassoni, S. Worley, R. Sorrentino, D. Steinhaus, J. M. Wolkowicz, Z. A. Syed, and and the AOP Study Investigators Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study Europace, November 1, 2007; 9(11): 1024 - 1030. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||